Patents matching “vaccine”

US 6867353

Production method of recombinant rotavirus structural proteins and vaccine composition

Exploregen Inc. · Granted Mar 15, 2005 · Expires Mar 10, 2025

US 6858211

Vaccines against Escherichia coli O157 infection

The United States of America, as represented by the Department of Health and Human Services · Granted Feb 22, 2005 · Expires Feb 17, 2025

US 6855322

Isolation and purification of P. falciparum merozoite protein-142 vaccine

The United States of America as represented by the Secretary of the Army · Granted Feb 15, 2005 · Expires Feb 10, 2025

US 6828416

Recombinant multivalent malarial vaccine against Plasmodium falciparum

The United States of America, as represented by the Department of Health and Human Services · Granted Dec 7, 2004 · Expires Dec 2, 2024

US 6811787

Over-expressing homologous antigen vaccine and a method of making the same

The Regents of the University of California · Granted Nov 2, 2004 · Expires Oct 28, 2024

US 6797275

Method of immunizing humans against Salmonella typhi using a Vi-rEPA conjugate vaccine

The United States of America, as represented by the Department of Health and Human Services · Granted Sep 28, 2004 · Expires Sep 23, 2024

US 6793927

Construction of Pasteurella haemolytica vaccines

The United States of America as Represented by the Secretary of the Department of Agriculture · Granted Sep 21, 2004 · Expires Sep 16, 2024

US 6787145

Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 7, 2004 · Expires Sep 2, 2024

US 6783763

Polyepitopic proteinic fragments of the E6 and E7 HPV proteins, production and use thereof in vaccines

Peptide Immune Ligands · Granted Aug 31, 2004 · Expires Aug 26, 2024

US 6770273

Vaccine based on attenuated Haemophilus somnus

The Regents of the University of California · Granted Aug 3, 2004 · Expires Jul 29, 2024

US 6770479

Anthrax vaccine

The United States of America as represented by the Secretary of the Army · Granted Aug 3, 2004 · Expires Jul 29, 2024

US 6752993

Abundant extracellular product vaccines and methods for their production and use

The Regents of the University of California · Granted Jun 22, 2004 · Expires Jun 17, 2024

US 6734172

Surface receptor antigen vaccines

PACIFIC NORTHWEST RESEARCH INSTITUTE · Granted May 11, 2004 · Expires May 6, 2024

US 6713284

Bacterial superantigen vaccines

The United States of America as represented by the Secretary of the Army · Granted Mar 30, 2004 · Expires Mar 25, 2024

US 6713066

Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2

The United States of America, as represented by the Department of Health and Human Services · Granted Mar 30, 2004 · Expires Mar 25, 2024

US 6706873

Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines

The United States of America, as represented by the Department of Health and Human Services · Granted Mar 16, 2004 · Expires Mar 11, 2024

US 6703016

Apoptotic bodies, monocyte derived cells containing the same, a process for their preparation and their uses as vaccines

I.D.M. Immuno-Designed Molecules · Granted Mar 9, 2004 · Expires Mar 4, 2024

US 6699674

Expression and refolding of truncated recombinant major outer membrane protein antigen (R56) of orientia tsutsugamushi and its use in antibody based detection assays and vaccines

United States of America as represented by the Secretary of the Air Force · Granted Mar 2, 2004 · Expires Feb 26, 2024

US 6696242

Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines

The United States of America, as represented by the Department of Health and Human Services · Granted Feb 24, 2004 · Expires Feb 19, 2024

US 6689367

Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences

The United States of America, as represented by the Department of Health and Human Services · Granted Feb 10, 2004 · Expires Feb 5, 2024

US 6685948

Replication-defective dengue viruses that are replication-defective in mosquitoes for use as vaccines

The United States of America, as represented by the Department of Health and Human Services · Granted Feb 3, 2004 · Expires Jan 29, 2024

US 6686190

Methods for enhancing the production of viral vaccines in cell culture

The Regents of the University of California · Granted Feb 3, 2004 · Expires Jan 29, 2024

US 6685949

Lipooligosaccharide based vaccine for prevention of moraxella (branhamella)catarrhalis infections in humans

The United States of America, as represented by the Department of Health and Human Services · Granted Feb 3, 2004 · Expires Jan 29, 2024

US 6685944

Modified HCV peptide vaccines

The United States of America, as represented by the Department of Health and Human Services · Granted Feb 3, 2004 · Expires Jan 29, 2024